$IBIO stock has now risen 13% today, according to our price data from Polygon. There has been approximately $5,661,797 of trading volume.
Here is what we see in our data on $IBIO (you can track the company live on Quiver's $IBIO stock page):
$IBIO Insider Trading Activity
$IBIO insiders have traded $IBIO stock on the open market 4 times in the past 6 months. Of those trades, 4 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $IBIO stock by insiders over the last 6 months:
- FELIPE DURAN (Chief Financial Officer) purchased 24,835 shares for an estimated $50,131
- MARTIN BRENNER (See Remarks) purchased 12,336 shares for an estimated $24,918
- MARC BANJAK (Chief Legal Officer) has made 2 purchases buying 13,934 shares for an estimated $23,055 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$IBIO Hedge Fund Activity
We have seen 33 institutional investors add shares of $IBIO stock to their portfolio, and 22 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MILLENNIUM MANAGEMENT LLC added 1,549,850 shares (+inf%) to their portfolio in Q1 2026, for an estimated $2,944,715
- AFFINITY ASSET ADVISORS, LLC added 1,050,000 shares (+51.0%) to their portfolio in Q1 2026, for an estimated $1,995,000
- CITADEL ADVISORS LLC added 956,429 shares (+inf%) to their portfolio in Q1 2026, for an estimated $1,817,215
- LOGOS GLOBAL MANAGEMENT LP removed 700,000 shares (-35.0%) from their portfolio in Q1 2026, for an estimated $1,330,000
- ECOR1 CAPITAL, LLC removed 645,000 shares (-28.9%) from their portfolio in Q1 2026, for an estimated $1,225,500
- VANGUARD GROUP INC added 609,079 shares (+222.2%) to their portfolio in Q4 2025, for an estimated $1,175,522
- AMERIPRISE FINANCIAL INC removed 584,368 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $1,110,299
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$IBIO Price Targets
Multiple analysts have issued price targets for $IBIO recently. We have seen 3 analysts offer price targets for $IBIO in the last 6 months, with a median target of $5.0.
Here are some recent targets:
- Martin Auster from Raymond James set a target price of $5.0 on 06/08/2026
- Keay Nakae from Chardan Capital set a target price of $5.0 on 04/09/2026
- Catherine Novack from Jones Trading set a target price of $7.0 on 03/03/2026
You can track data on $IBIO on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
